Recommended procedures for the treatment and diagnostics of hepatocellular carcinoma
Authors:
R. Brůha 1; J. Šperl 1
; P. Urbánek 1; J. Špičák 2; I. Kiss 3
; V. Válek4 ,6; V. Mejzlík 5; M. Oliverius 5; E. Honsová 7; P. Husa Za Pracovní Skupinu Hcc 8 2011
Authors‘ workplace:
Česká hepatologická společnost ČLS JEP
1; Česká gastroenterologická společnost ČLS JEP
2; Česká onkologická společnost ČLS JEP
3; Česká společnost intervenční radiologie ČLS JEP
4; Česká transplantační společnost
5; Radiologická společnost ČLS JEP
6; Společnost českých patologů ČLS JEP
7; Společnost infekčního lékařství ČLS JEP
8
Published in:
Gastroent Hepatol 2012; 66(2): 83-92
Category:
Hepatology: Best Practises
Sources
1. International Agency for Cancer Reseach. GLOBOCAN 2002: http://www-dep.iarc.fr Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127 (5 Suppl 1): S5–S16.
2. AASLD guidelines for HCC. http://www.aasld.org/practiceguidelines/Documents//Bookmarked%20Practice%20Guidelines//HCCUpdate2010.pdf.
3. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130(7): 417–422.
4. Yuen MF, Tanaka Y, Fong DY et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 2009; 50(1): 80–88.
5. Lok AS, Seeff LB, Morgan TR et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009; 136(1): 138–148.
6. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924–926.
7. Singal A, Volk ML, Waljee A et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009; 30(1): 37–47.
8. Lok AS, Sterling RK, Everhart JE et al. HALT-C Trial Group. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 2010; 138(2): 493–502.
9. Bruix J, Sherman M. Management of Hepatocellular Carcinoma: An Update. Hepatology 2011; 53(3): 1020–1022.
10. International Consensus group for hepatocellular neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49(2): 658–664.
11. Forner A, Vilana R, Ayuso C et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47(1): 97–104.
12. Sangiovanni A, Manini MA, Iavarone M et al. The diagnostic and economic impact of contrast paging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010; 59(5): 638–644.
13. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual 7th edition. Springer, 2010.
14. Pugh RNH, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60(8): 646–664.
15. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33(2): 464–470.
16. Forner A, Reig ME, de Lope CR et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010; 30(1): 61–74.
17. Llovet, JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25(2): 181–200.
18. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127 (Suppl 1): S268–276.
19. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11): 693–699.
20. Livraghi T, Meloni F, Di Stasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47(1): 82–89.
21. Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma
22. Cho YK, Kim JK, Kim MY et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49(2): 453–459.
23. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004; 127 (5 Suppl 1): S179–188.
24. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37(2): 429–442.
25. Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359(4): 378–390.
26. Cheng AL, Kang YK, Chen Z et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, doubleblind, placebo-controlled trial. Lancet Oncol 2009; 10(1): 25–34.
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
2012 Issue 2
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Most read in this issue
- Hepatorenal syndrome in patients with acute alcoholic hepatitis
- Current approach to anaemia in patients with inflammatory bowel disease
- Treatment of achalasia – the current approach and personal experience
- Prof. Jiří Nevoral on the occasion of his 70th birthday